Evidence map›Paper›PMID 38937606›Full record

ArticleNature genetics2024

A common flanking variant is associated with enhanced stability of the FGF14-SCA27B repeat locus.

David Pellerin, Giulia F Del Gobbo, Madeline Couse, Egor Dolzhenko, Sathiji K Nageshwaran, Warren A Cheung, Isaac R L Xu, Marie-Josée Dicaire, Guinevere Spurdens, Gabriel Matos-Rodrigues and 32 more

Abstract read
In one paragraph

Article in Nature genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A haplotype-resolved view of human gene regulation.bioRxiv : the preprint server for biology · 2025
    Article
  14. Exploration of Neurodegenerative Diseases Using Long-Read Sequencing and Optical Genome Mapping Technologies.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  15. Article
  16. Article
  17. High Prevalence of the Intronic GAA-Neurology. Genetics · 2025
    Article
  18. The ZFHX3 GGC Repeat Expansion Underlying Spinocerebellar Ataxia Type 4 has a Common Ancestral Founder.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

42 authors.

David PellerinDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.
Giulia F Del Gobbo *Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Madeline Couse *Centre for Computational Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Egor Dolzhenko *Pacific Biosciences, Menlo Park, CA, USA.ORCID http://orcid.org/0000-0002-3296-0677
Sathiji K Nageshwaran *Department of Psychiatry, Department of Neuroscience and Department of Genetics and Genomic Sciences, Friedman Brain Institute Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-3931-2573
Warren A Cheung *Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO, USA.ORCID http://orcid.org/0000-0003-0267-7464
Isaac R L Xu *Dr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Marie-Josée Dicaire *Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0009-0003-0938-1268
Guinevere SpurdensDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.
Gabriel Matos-RodriguesLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Igor StevanovskiGenomics and Inherited Disease Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-7713-1979
Carolin K ScribaCentre for Medical Research University of Western Australia and Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.ORCID http://orcid.org/0000-0001-9874-3846
Adriana RebeloDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID http://orcid.org/0000-0001-5669-7415
Virginie RothLaboratoire de Génétique, CHRU de Nancy, Nancy, France.
Marion WandzelLaboratoire de Génétique, CHRU de Nancy, Nancy, France.
Céline BonnetLaboratoire de Génétique, CHRU de Nancy, Nancy, France.ORCID http://orcid.org/0000-0002-6799-0438
Catherine AshtonDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0001-8042-6180
Aman AgarwalTisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0009-0005-5813-7047
Cyril PeterDepartment of Psychiatry, Department of Neuroscience and Department of Genetics and Genomic Sciences, Friedman Brain Institute Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-9190-8724
Dan HassonTisch Cancer Institute Bioinformatics for Next Generation Sequencing (BiNGS) Core, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nadejda M TsankovaDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ken DewarDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.
Phillipa J LamontDepartment of Neurology, Royal Perth Hospital, Perth, Western Australia, Australia.
Nigel G LaingCentre for Medical Research University of Western Australia and Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.ORCID http://orcid.org/0000-0001-5111-3732
Mathilde RenaudLaboratoire de Génétique, CHRU de Nancy, Nancy, France.
Henry HouldenDepartment of Neuromuscular Diseases, UCL Queen Square Institute of Neurology and The National Hospital for Neurology and Neurosurgery, University College London, London, UK.ORCID http://orcid.org/0000-0002-2866-7777
Matthis SynofzikDivision of Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-2280-7273
Karen UsdinLaboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Andre NussenzweigLaboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.
Marek NapieralaDepartment of Neurology, O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhao ChenDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Hong JiangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Ira W DevesonGenomics and Inherited Disease Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0003-3861-0472
Gianina RavenscroftCentre for Medical Research University of Western Australia and Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia.
Schahram AkbarianDepartment of Psychiatry, Department of Neuroscience and Department of Genetics and Genomic Sciences, Friedman Brain Institute Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-7700-0891
Michael A EberlePacific Biosciences, Menlo Park, CA, USA.
Kym M BoycottChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
Tomi PastinenGenomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO, USA.ORCID http://orcid.org/0000-0003-4016-5021
All of Us Research Program Long Read Working Group
Bernard BraisDepartment of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0003-1394-3561
Stephan ZuchnerDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID http://orcid.org/0000-0002-8498-5235
Matt C DanziDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL, USA. m.danzi@med.miami.edu.ORCID http://orcid.org/0000-0003-1568-5965

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
Understanding the mutational mechanism responsible for the Repeat Expansion DiseasesZIADK057808 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI USDIN, KAREN P. · 2009 to 2025
$14.1M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Single Chromatin Fiber Sequencing and Longitudinal Epigenomic Profiling in HIV+ Brain Cells Exposed to Narcotic and StimulantDP1DA056018 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Schahram Akbarian · 2022 to 2026
$5.9M
Resolving SARS-Cov-2 tropism and COVID19 pathology in the brainR01NS106229 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Nadejda Mincheva Tsankova · 2019 to 2026
$3.5M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Chromatin Plasticity, Transcriptional Activity and Kinetics in Developing and Adult Human Astrocyte and Oligodendroglial LineagesRF1DA048810 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TSANKOVA, NADEJDA MINCHEVA · 2019 to 2019
$1.8M
Creating an advanced multi-ancestral resource and tools for short tandem repeat analysis in the AOURP researcher workbenchR21HG013397 · NHGRI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DANZI, MATTHEW CHRISTOPHER, ZUCHNER, STEPHAN · 2023 to 2023
$422k
Deutsche Forschungsgemeinschaft (German Research Foundation) 441409627Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 189963Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) GP1-155867NCATS NIH HHS UL1 TR004419NCI NIH HHS P30 CA196521NHGRI NIH HHS R21 HG013397NIDA NIH HHS DP1 DA056018NIDA NIH HHS RF1 DA048810NIH HHS S10 OD026880NIH HHS S10 OD030463NINDS NIH HHS R01 NS072248NINDS NIH HHS R01 NS106229Ontario Genomics Institute (OGI) OGI-147U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30CA196521U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD026880U.S. Department of Health & Human Services | National Institutes of Health (NIH) S10OD030463U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) HHSN261201500003U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS) UL1TR004419U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) R21HG013397U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 2R01NS072248-11A1U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS106229U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) DP1DA056018U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) RF1DA048810Wellcome Trust
6 · The paper itself

Abstract

The factors driving or preventing pathological expansion of tandem repeats remain largely unknown. Here, we assessed the FGF14 (GAA)·(TTC) repeat locus in 2,530 individuals by long-read and Sanger sequencing and identified a common 5'-flanking variant in 70.34% of alleles analyzed (3,463/4,923) that represents the phylogenetically ancestral allele and is present on all major haplotypes. This common sequence variation is present nearly exclusively on nonpathogenic alleles with fewer than 30 GAA-pure triplets and is associated with enhanced stability of the repeat locus upon intergenerational transmission and increased Fiber-seq chromatin accessibility.

Indexed as

AllelesFibroblast Growth FactorsGenetic LociGenetic VariationHaplotypesHumansfibroblast growth factor 14Fibroblast Growth Factors

Identifiers

PMID38937606
PMCPMC11440897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.